Champions Oncology, Inc

Short Term Long Term Short Term Comparison Long Term Comparison
  • CSBR
  • 1d0.00%
  • 1w0.40%
  • 1m-8.59%
  • 1y4.17%
ATH
  • ATH Price$94.80
  • ATH Date1990-08-24
  • % since ATH-94.73%
  • % to ATH1,796.00%
ATL
  • ATL Price$0.07
  • ATL Date2003-02-20
  • % from ATL6,844.44%
  • Last Low Price$0.072
  • Last Low Date2003-02-20
  • % From Last Low6,844.44%
IPO
  • IPO Price$0.05
  • % Current ROI USD10,660.98%
  • ATH Price$94.80
  • % ROI ATH 13,166,666.67%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="CSBR"]

Key Data [addtoany]

Current price $5
Sector Healthcare
Industry Biotechnology
Today's High/Low $5/$5
Volume 0.00
Previous Close $5
52 Week High/Low $7.32/$4.17
Market Cap 67,969,000.00
P/E Ratio 0
Forward P/E 1 Yr. $22.88
Earnings Per Share(EPS) $-0.34
Annualized Dividend $0
$5
[addtoany]

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States.
Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice.
The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune-deficient mice.
It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process.
The company markets its products through internet, word of mouth, and sales force to patients and physicians.
The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Annual Data | Millions of US $ except per share data 2019-04-302018-04-302017-04-302016-04-302015-04-302014-04-302013-04-302012-04-302011-04-302010-04-302009-04-302008-04-302007-04-302006-04-302005-04-302004-04-302003-04-302002-04-302001-04-302000-04-30
Cash on hand $3.24$0.86$3.30$2.59$9.36---------------
Receivables $1.98$3.92$0.73$0.73$1.06$1.33--------------
Inventory -$0$0$0$0$0$0$0------$0.02$0.03$0.02$0.03$0.03$0.02
Pre-Paid Expenses --------------------
Other Current Assets -$0.29$0.30$0.44$0.35$0.38$0.32$0.21$0.28$0.54$1.13$0.05---$0700000$0.01$0.01$0.02$0.23
Total Current Assets $7.92$5.06$5.87$4.34$10.76$0$0$0------------
Property, Plant, And Equipment $2.55$2.08$1.22$0.62$0.45$0.43$0.41$0.56$0.15$0.11$0.08---$0.15$0.20$0.25$0.29$0.32$0.34
Long-Term Investments --------------------
Goodwill And Intangible Assets $0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.67$0.66--------
Other Long-Term Assets $0.13$0.27$0.26$0.15$0.16$0.17$0.19$0.15---$0.23$0.18-$0.01$0.01$0.01$0.01$0.01$0.01
Total Long-Term Assets $3.34$3.02$2.14$0.15----------------
Total Assets $11.27$8.08$8.01$5.78$12.05$8.87$11.65$6.92$12.65$3.93$4.62$4.65$0.18$0100000$0.27$0.39$0.49$0.79$0.88$1.42
Total Current Liabilities $8.03$7.45$7.45$5.31$3.80$3.66$2.93$3.49$3.50$2.09$2.70$1.01$0.45$0.67$0.63$0.59$0.69$0.78$0.71$0.50
Long Term Debt -$0.02$0.04$0.06$0.09$0$0$0----------$0200000$0.01
Other Non-Current Liabilities $1$0.61$0.16$0.23$0.19$2.01$1.05$0.56$0.97$0.08------$0400000$0700000$0.01$0.02
Total Long Term Liabilities $1$0.62$0.16$0.23----------------
Total Liabilities $9.03$8.08$7.61$5.54$3.99$5.67$3.98$4.04$4.47$2.17$2.70$1.01$0.45$0.67$0.63$0.59$0.70$0.79$0.73$0.52
Common Stock Net $0.01$0.01$0.01$0900000$0900000$0.07$0.04$0.04$0.04$0.04$0.03$0.03$0.03$0.02$0.02$0900000$0900000$0900000$0800000$0900000
Retained Earnings (Accumulated Deficit) $-70.70$-70.83$-69.35$-62.47$-52.02$0$0$0------------
Comprehensive Income -$0$0$0$0$0$0$0------------
Other Share Holders Equity --------------------
Share Holder Equity $2.24$0300000$0.40$0.24$8.06$3.20$7.68$2.88$8.18$1.77$1.92$3.64------$0.15$0.89
Total Liabilities And Share Holders Equity --------------------